One ticker, one page: health score, red flags, fundamentals, who’s buying, cash & dilution, and the latest catalyst — every module built from SEC filings, ready to print or share.
start from a preset — you get the bundle, then edit it
or pick exactly what you want — 5 selected
These add one extra lookup each — still fine to combine.
Heavy modules — each one runs on its own. Checking one clears the rest, because it reads several filings live and would otherwise time the page out.
Your selection lives in the link, so a built report is shareable and bookmarkable. Educational information from public filings — not investment advice.
Assembling SFES’s research report…
Pulling SEC filings
Parsing XBRL fundamentals
Scoring quality, value & momentum
Checking who’s buying
Rendering
SFES SAFEGUARD SCIENTIFICS INC
Research report · from SEC EDGAR
Close: Source: no end-of-day close is held for this ticker on this build.
SAFEGUARD SCIENTIFICS INC (SFES). Revenue is $34.8M. It is not yet profitable. Our health score is A (90/100). No major red flags on file. It funds itself; low dilution risk.
Revenue and growth: REPORTED SEC XBRL companyfacts, us-gaap:Revenues; as of FY ending 2009-12-31; Form 10-K 0001193125-12-094470, filed 2012-03-02.
Net income: DERIVED SEC XBRL companyfacts, us-gaap:ProfitLoss; as of TTM ending 2023-12-31; Form 10-K 0001437749-24-009415, filed 2024-03-26.
Health score: UNVALIDATED StockTools.ai health score, from SEC XBRL companyfacts and end-of-day prices; as of cash as of 2023-12-31. Method not verified against an independent source.
SEC Form 4, open-market purchases (P) and sales (S); as of no Form 4 in the window read.
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 0
DERIVED SEC Form 4, open-market purchases (P) and sales (S); as of no Form 4 in the window read. No as-of date carried.
Congress buys
0
DERIVED Periodic transaction reports filed under the STOCK Act; as of no report in the window read. No single source document identified; no as-of date carried.
13F fund holders
0
DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
DERIVED SEC XBRL companyfacts, balance sheet, us-gaap:CashAndCashEquivalentsAtCarryingValue; as of 2023-12-31.
Operating cash flow
-$3.3M
REPORTED SEC XBRL companyfacts, cash flow statement, us-gaap:NetCashProvidedByUsedInOperatingActivities; as of FY ending 2023-12-31.
Est. runway
~34 mo
DERIVED Cash divided by operating burn, from SEC XBRL companyfacts; as of cash as of 2023-12-31; operating cash flow over FY ending 2023-12-31.
Going concern
None
SEC full-text search for "substantial doubt" in 10-K and 10-Q filings; as of filed 2025-08-08 to 2026-11-11.
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices. Each figure prints its own source and the date it is true as of beneath it, with REPORTED for a figure the source published and DERIVED or UNVALIDATED for our arithmetic; nothing is fabricated or predicted. Filings lag 40 to 90 days. Educational, not investment advice. Generated 2026-11-11 by stocktools.ai.
Congress counts: DERIVED Periodic transaction reports filed under the STOCK Act; as of no report in the window read. No single source document identified; no as-of date carried.
Fund holders: DERIVED SEC Form 13F-HR, the funds we track; as of no tracked fund reports a position. No single source document identified; no as-of date carried.
Cash need: DERIVED Cash divided by operating burn, from SEC XBRL companyfacts; as of cash as of 2023-12-31; operating cash flow over FY ending 2023-12-31.
DERIVED SEC XBRL companyfacts, us-gaap:EarningsPerShareDiluted; as of TTM ending 2023-12-31; Form 10-K 0001437749-24-009415, filed 2024-03-26.